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Motivation and objectives
Sight is likely the most important human sense. In 
this context, it is well known that human neurode-
generative diseases, such as Parkinson’s disease 
(PD) and the neuromuscular disorders called dys-
troglycanopathies (DGPs), cause retinal impair-
ments and consequently vision loss (Muntoni and 
Voit, 2004; Bodis-Wollner, 2009). We have char-
acterized the expression of PD-related genes 
SNCA (α-synuclein), PARK 2 (parkin) and UCHL 
1 in the mammalian retina (Martínez-Navarrete 
et al., 2007; Esteve-Rudd et al., 2010) and have 
found that a number of DGP-related genes are 
expressed in this tissue as well (Martín-Nieto et al., 
2012). We have also described morphological 
(Cuenca et al., 2005) and proteomic (Esteve-
Rudd et al., 2013) alterations taking place in the 
primate retina associated with parkinsonism. 
In this work we have attempted to catalog all 
known genes linked to PD and DGPs expressed 
in the human retina and quantify their mRNA lev-
els. We have also focused in identifying transcript 
variants of these genes, in order to possibly cor-
relate them with propensity to visual impairment.
Methods
Human retina reference RNA extracted from a 
pool of 29 Caucasian donors (both sexes, ages 
20-60) was obtained from Clontech-BD. Total RNA 
was reverse-transcribed and amplified using the 
SMART PCR cDNA Synthesis kit (Clontech-BD). The 
obtained cDNA was mechanically cut into 100 
bp fragments by ultrasonication, and a cDNA 
library was constructed using NEBNext reagents 
(New England Biolabs). There after, the cDNA was 
sequenced on an Illumina HiSeq 2000 system by 
Otogenetics Corp. using a read length of 100 bp, 
paired-end sequencing and a depth coverage 
of 100 million reads. Subsequent bioinformatic 
analyses of the obtained sequenceswere per-
formed by Otogenetics and Genometra com-
panies. The data processing protocol included 
the following computational tools:
•	 Sequence data quality control: FastQC soft-
ware (http://www.bioinformatics.babraham.
ac.uk/projects/fastqc/)
•	 Sequence data files handling: Samtools 
(http://samtools.sourceforge.net/)
•	 Mapping: TopHat software (http://tophat.
cbcb.umd.edu/), including the ultra high-
throughput short read aligner Bowtie (http://
bowtie.cbcb.umd.edu).
•	 Transcript identification: Cufflinks (http://cuf-
flinks.cbcb.umd.edu/).
•	 Expression level quantification: Cufflinks 
software and Qualimap platform (García-
Alcalde et al., 2012; http://qualimap.bioinfo.
cipf.es/). 
•	 Sequence data alignment visualization: 
Integrative Genome Viewer (IGV) (www.broa-
dinstitute.org/igv/v1.4).
Results and Discussion
We have evidenced that most of the neurode-
generative disease-related genes assessed are 
expressed in the human retina, and their mRNA 
expression levels have been quantitated in terms 
of fragments per kilobase per million reads (FPKM) 
through RNA-Seq technology. These include the 
PD-linked genes SNCA, PARK2, UCHL1, DJ1 and 
PINK1, and the DGP-linked genes POMT1, POMT2, 
POMGNT1, FKTN (fukutin), FKRP and LARGE, 
among others. Besides, we have character-
ized the expression profile of such genes in the 
retina by determining their exonic, intronic and 
exon-intron junction expression levels. These data 
have allowed us to examine the alternative splic-
ing pattern of particular genes, and as a result 
a number of new transcript variants have been 
identified. We are currently attempting to cor-
relate particular splice variants with loss of gene 
function. We believe that this research should be 
of potential usefulness to understand the molec-
ular bases of sight deficiencies associated with 
neurodegenerative disorders.
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